Black Diamond Therapeutics (BDTX) P/FCF US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/FCF | -1.88 | -0.76 | -1.85 | -1.89 | 4.67 | 3.47 | ||
| Changes by years, y/y, % | -91% | -59% | +142% | +2% | -347% | |||
Black Diamond Therapeutics. P/FCF
Black Diamond Therapeutics. P/FCF, changes, %
Black Diamond Therapeutics (BDTX) P/FCF US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/FCF | -2.55 | 3.25 | 7.88 | 10.1 | 4.68 | 3.47 | ||
| Changes by years, y/y, % | +27% | -184% | -264% | -290% | -284% | |||
| Changes by quarters, q/q, % | -52% | -228% | +143% | +28% | -53% | |||